denileukin diftitox
Drug Details
- Generic Name
- denileukin diftitox
- Brand Names
- N/A
- Application Number
- Sponsor
- FUJIFILM Diosynth Biotechnologies UK Ltd.
- NDC Codes
- 1
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- N/A
- Active Ingredients
- DENILEUKIN DIFTITOX-CXDL
Indications and Usage
1 INDICATIONS AND USAGE LYMPHIR is indicated for the treatment of adult patients with relapsed or refractory Stage I-III cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy. LYMPHIR is an IL2-receptor-directed cytotoxin indicated for the treatment of adult patients with relapsed or refractory Stage I-III cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy. ( 1 )